180 Life Sciences Corp. (NASDAQ: ATNF)
$2.08
-0.0500 ( -2.35% ) 128.5K
180 Life Sciences Corp is a clinical-stage biotechnology company. It is focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation and fibrosis by employing innovative research, and, where appropriate, combination therapy.
Market Data
Open
$2.08
Previous close
$2.13
Volume
128.5K
Market cap
$1.91M
Day range
$2.00 - $2.28
52 week range
$1.31 - $21.28
SEC Fillings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 15 | Jan 29, 2024 |
| 8-k | 8K-related | 17 | Jan 17, 2024 |
| 8-k | 8K-related | 13 | Jan 16, 2024 |
| 4 | Insider transactions | 1 | Dec 28, 2023 |
| def | Proxies and info statements | 7 | Dec 26, 2023 |
| 8-k | 8K-related | 13 | Dec 21, 2023 |
| 8-k | 8K-related | 13 | Dec 20, 2023 |
| 4 | Insider transactions | 1 | Dec 18, 2023 |
| 4 | Insider transactions | 1 | Dec 18, 2023 |
| 8-k | 8K-related | 13 | Dec 15, 2023 |